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Abstract
Introduction Current metabolomics approaches to unravel impact of diet- or lifestyle induced phenotype variation and shifts 
predominantly deploy univariate or multivariate approaches, with a posteriori interpretation at pathway level. This however 
often provides only a fragmented view on the involved metabolic pathways.
Objectives To demonstrate the feasibility of using Goeman’s global test (GGT) for assessment of variation and shifts in 
metabolic phenotype at the level of a priori defined pathways.
Methods Two intervention studies with identified phenotype variations and shifts were examined. In a weight loss (WL) 
intervention study obese subjects received a mixed meal challenge before and after WL. In a polyphenol (PP) intervention 
study obese subjects received a high fat mixed meal challenge (61E% fat) before and after a PP intervention. Plasma samples 
were obtained at fasting and during the postprandial response. Besides WL- and PP-induced phenotype shifts, also correlation 
of plasma metabolome with phenotype descriptors was assessed at pathway level. The plasma metabolome covered organic 
acids, amino acids, biogenic amines, acylcarnitines and oxylipins.
Results For the population of the WL study, GGT revealed that HOMA correlated with the fasting levels of the TCA cycle, 
BCAA catabolism, the lactate, arginine–proline and phenylalanine–tyrosine pathways. For the population of the PP study, 
HOMA correlated with fasting metabolite levels of TCA cycle, fatty acid oxidation and phenylalanine–tyrosine pathways. 
These correlations were more pronounced for metabolic pathways in the fasting state, than during the postprandial response. 
The effect of the WL and PP intervention on a priori defined metabolic pathways, and correlation of pathways with insulin 
sensitivity as described by HOMA was in line with previous studies.
Conclusion GGT confirmed earlier biological findings in a hypothesis led approach. A main advantage of GGT is that it 
provides a direct view on involvement of a priori defined pathways in phenotype shifts.
Keywords Goeman’s global test · Metabolic pathways · Phenotype shifts
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1 Introduction
Health is maintained by well-orchestrated interactions 
between physiological processes. These processes have 
to function in a changing environment and thus they col-
lectively strive to maintain homeostasis by continuous 
adaptations. The ability to adapt to stressors such as diet 
and exercise has been coined as phenotypical flexibil-
ity (PF) and has been proposed as a measure for health 
(van Ommen et al. 2014; Huber et al. 2011). PF has been 
brought forward as a broad concept (van Ommen et al. 
2014), but comprises the well-established concept of 
metabolic flexibility (MF), which is the efficiency of the 
postprandial switch between fasting lipid catabolism to 
postprandial carbohydrate anabolism (Corpeleijn et al. 
2009). Several studies have claimed that phenotypical flex-
ibility reflects the capacity to adapt to the new situation 
and this provides a better indication of health and disease 
risk comparing to fasting measure (Elliott et al. 2007; Vis 
et al. 2015; Fiamoncini et al. 2018). Challenge tests have 
been put forward to measure the phenotypic flexibility of 
a biological system by recording how well the system is 
able to undo a perturbation bringing the system back to 
steady state.
In earlier studies univariate statistics was used to find 
differences between metabolic phenotype, at the level of 
baseline metabolism or in the response to a challenge (van 
Ommen et al. 2014; Vis et al. 2015; Fiamoncini et al. 2018). 
This approach is compromised by the multiple testing prob-
lem, and also cannot unambiguously establish whether a 
phenotype shift is better reflected in a shift in fasting metab-
olism or in an altered response to a dietary challenge. In this 
work we will explore an approach where we exploit prior 
knowledge on involvement of metabolic pathways in shifts 
in fasting metabolism or altered postprandial responses. In 
order to exploit this prior knowledge we will use Goeman’s 
global test, which is a robust test to identify whether metabo-
lites that are connected in a pathway collectively respond to 
a change in conditions (Hendrickx et al. 2012). In the metab-
olomics field, predefined groups of pathways or functional 
modules can be used (Kanehisa and Goto 2000; Kanehisa 
et al. 2006, 2010).
We will explore this approach in two studies, schemati-
cally depicted in Fig. 1, where mixed-meal challenges were 
carried out to assess the efficacy of two types of dietary 
interventions. The first study examined whether a mixed 
meal challenge response could provide a readout for a shift 
in phenotypical flexibility upon weight loss (WL) in obese 
male subjects. This study showed a significant improvement 
Fig. 1  Schematic overview of Goeman’s global testing of differ-
ences in pathways between different phenotype groups (lean, obese) 
and due to WL and PP interventions. In the WL and PP intervention 
studies respectively also control (CTRL) and placebo groups were 
included. For all groups plasma was sampled at fasting state (T0) and 
during the postprandial response to a meal challenge. The postpran-
dial response was captured in the incremental area under the curve 
(iAUC). The effect of the WL, CRTL, PP and placebo interventions 
was summarized in ΔT0 and ΔiAUC. The vertical arrows indicate 
application of Goeman’s test (indicated in red) to comparison of lean 
versus obese (based on T0 and iAUC) and on comparison of WL ver-
sus CRTL and PP versus placebo groups (based on ΔT0 and ΔiAUC)
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in insulin sensitivity after WL (Joris et al. 2016) and thus 
provides a relevant case for testing our approach. In the sec-
ond study, the effect of long term polyphenol (PP) consump-
tion on phenotypical flexibility was also assessed by means 
of a mixed meal challenge. The PP intervention did not have 
an effect on insulin sensitivity and MF but increased fasting 
level and postprandial fat oxidation as compared to placebo 
(Most et al. 2016). In both studies the responses of amino 
acids and acylcarnitines were measured, as well as metabo-
lites related to the TCA cycle. This set of metabolites was 
selected based on previous studies that most convincingly 
related them with the ability to effectively switch from lipid 
to carbohydrate metabolism in the postprandial phase, i.e. 
MF.
We explored Goeman’s global testing approach (Hen-
drickx et al. 2012; Goeman et al. 2004) to assess the effect 
of the WL and PP intervention on both fasting (at T0) and 
mixed meal challenge responses. Originally the Goeman 
test was developed for gene-expression data. This test is on 
predefined groups of genes thereby diminishing the multi-
ple testing problems associated with testing all genes sepa-
rately. If a treatment–control study is considered the Goeman 
test will tell how well the predefined genes can predict the 
membership of the treatment or control group. Classically 
logistic regression is the tool used for the prediction. The 
significance of the result is established by a permutation 
test. In this test the membership of the two groups, either 
treated or control, is randomized and this performance is 
compared to that of the original data. If now instead of gene-
expression data, metabolomics data is used exactly the same 
statistical procedure can be followed (Hendrickx et al. 2012). 
Furthermore, we will use this approach to establish correla-
tions between phenotypical parameters (insulin sensitivity 
and MF) and metabolic pathways.
2  Materials and methods
2.1  Subject characteristics
2.1.1  Weight loss intervention study
29 abdominally overweight/obese men (BMI = 30.0 ± 0.5 kg/
m2 for WL and 30.7 ± 0.7 kg/m2 for control groups) partici-
pated in the study. None of the subjects were diagnosed with 
clinical diseases. Subjects characteristics can be found in 
Supplementary Table S1-a.
2.1.2  Polyphenol intervention study
38 overweight and obese subjects (BMI = 28.5 ± 0.8 for pla-
cebo and BMI = 29.6 ± 0.8 kg/m2 for PP intervention groups) 
participated in this study, 28 subjects that provided complete 
data were randomly selected for metabolomics analysis. Char-
acteristics of the subjects who completed the study are sum-
marized in Supplementary Table S1-b.
2.2  Study design
2.2.1  Weight loss intervention study
Lean subjects were only studied cross-sectional, and obese/
overweight subjects before and after random assignment to a 
WL intervention of 8 weeks. Before and after the WL inter-
vention (D1 and D2), all subjects underwent a mixed meal 
challenge test and blood samples were collected during 4 h. 
Subjects were randomly assigned to either a WL or control 
(CTRL) program for 8 weeks, see Fig. 1 for a schematic depic-
tion. HOMA was calculated at both D1 and D2. Details on the 
design have been published (Joris et al. 2016).
2.2.2  Polyphenol intervention study
In this randomized, double-blind, placebo-controlled, parallel-
intervention trial, subjects received either a PP supplement 
(epigallocatechin gallate and resveratrol; 282 and 80 mg/day, 
respectively) or a placebo (partly hydrolyzed microcrystalline 
cellulose-filled capsules) for a period of 12 weeks to assess 
effects of PP supplementation on tissue-specific insulin sen-
sitivity (primary outcome) and plasma metabolic profile, fat 
oxidation, skeletal muscle oxidative capacity, and lipolysis 
(secondary outcomes). The supplementation period started the 
day after the last measurement in week 0 and was continued 
throughout measurements in week 12. In this study we use 
the data from the high-fat mixed meal (HFMM) challenges 
that were performed before supplementation was initiated, 
and after 12 weeks before supplementation was stopped, see 
Fig. 1 for a schematic depiction. In addition to HOMA, energy 
expenditure, respiratory quotient (RQ), fat and carbohydrate 
oxidation were measured by indirect calorimetry using the 
open-circuit ventilated hood system (Omnical; Maastricht 
University) and were calculated according to the formulas of 
Weir and Frayn, respectively. A hyperinsulinemic–euglycemic 
clamp with an isotope labelled glucose infusion tracer was 
performed to assess rate of disappearance (Rd, as measured 
for peripheral insulin sensitivity) and endogenous glucose pro-
duction (% EGP a measure for hepatic insulin resistance). Full 
details of the study can be found elsewhere (Most et al. 2016).
2.3  Sample collection
2.3.1  Weight loss intervention study
Subjects were asked not to perform any strenuous physical 
exercise or to consume alcohol and high-fat foods on the 
day before blood sampling. Blood samples were taken at 
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fasting and after mixed meal consumption both before and 
after the WL intervention at six time points (fasting (T0) 
and 30, 60, 120, 180 and 240 min in the postprandial state). 
The standardized mixed meal consisted of two muffins and 
300 ml 0% fat milk, which provided 1100 kcal: 56.6 g fat, 
26.5 g protein and 121 g carbohydrate. Metabolic profiling 
was performed on all time points. Full details can be found 
in Joris et al. (2016).
2.3.2  Polyphenol intervention study
After inserting a cannula into the antecubital vein, substrate 
oxidation was measured for 30 min under fasting condi-
tions (T0) and for 4 h after the ingestion of a liquid HFMM 
(625 kcal, 61% of energy from fat, 33% of energy from car-
bohydrate, 6% of energy from protein), which was consumed 
within 5 min at t = 0. Blood samples were taken under fast-
ing (0 min) and postprandial (t = 30, 60, 90, 120, 150, 180, 
210, and 240 min) conditions. Full details of the study can 
be found elsewhere (Most et al. 2016).
2.4  Plasma metabolic profiling
Full details on analytical procedures can be found in Faz-
elzadeh et al. (2018). In short, amino acids and biogenic 
amines, organic acids and acylcarnitines were measured for 
both the WL and PP intervention studies, with a total 170 
metabolites. Amino acids and biogenic amines in plasma 
were derivatized (Acc-TAG) and measured by a UPLC 
system which was interfaced to quadrupole mass spec-
trometer. Acylcarnitines in plasma were also measured by 
UPLC–MS, but without derivatization. Organic acids in 
plasma were measured by GC–MS, after oximation and 
silylation derivatization. Oxylipins were only analyzed for 
the WL study. First an SPE extraction was performed and 
subsequently a LC separation coupled to ESI on a triple 
quadrupole mass spectrometer. Oxylipins were detected in 
negative ion mode using dynamic SRM. Full details of these 
platforms have been described in earlier studies (Noga et al. 
2012; van der Kloet et al. 2009; Mihaleva et al. 2014; Faz-
elzadeh et al. 2018). Serum metabolites were measured by 
NMR in a quantitative manner, full experimental details can 
Fig. 2  P-value distribution of effect of WL on fasting state values in 
obese subjects (ΔWL T0 vs. Δ CTRL T0). a Effect of WL on chal-
lenge response values in obese subjects (iAUC WL vs. iAUC CTRL). 
b Effect of PP intervention on fasting state values in obese subjects 
(Δ PP T0 vs. Δ placebo T0). c Effect of PP intervention on challenge 
response values in obese subjects (iAUC PP vs. iAUC placebo). d 
Metabolites with P < 0.05 were coloured green and otherwise red
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be found in earlier work (Mihaleva et al. 2014). In short, 
serum samples were ultrafiltrated and automated quantum 
mechanical line shape fitting of 1H NMR spectra was per-
formed using PERCH in order to obtain absolute metabolite 
concentrations.
2.5  Statistical analysis
For pathway analysis, Goeman’s global test for metabo-
lomics was applied to test groups of covariates (or metab-
olites) for association with a response variable using the 
global test R library (Hendrickx et al. 2012; Goeman et al. 
2004). Nadir acylcarnitine values were defined as the lowest 
value achieved during the 4 h after the meal (Ramos-Roman 
et al. 2012). Δ nadir was calculated as difference between 
nadir and T0 values. All analyses were done using R (version 
3.1.2). As a reference method we used Analysis of Variance 
(ANOVA) for between group comparisons. Linear mixed 
modelling was used to assess the fasting comparison and dif-
ference of response effect between groups. P < 0.05 was con-
sidered to be statistically significant. To account for multiple 
testing, local false discovery rates (lFDR) were calculated 
for each metabolite (Strimmer 2008a, b). The postprandial 
response was considered as incremental area under the curve 
(iAUC), taking the fasting measurement (t0) as a reference. 
The iAUC was calculated in two ways. First, by considering 
that the AUC comprises both negative AUC (AUC−) and 
positive AUC (AUC+) contributions, we refer to this value 
as iAUC. Secondly, we also calculated the positive iAUC 
where the absolute values contributing to the curve were 
summed up, we refer to these values as piAUC (Carstensen 
et al. 2003; Pellis et al. 2012). For both iAUC and piAUC we 
use the trapezoidal calculation method (Senn 1990).
3  Results
3.1  Univariate assessment of intervention effects 
and correlations with phenotype parameters
3.1.1  Weight loss intervention study
Figure 2a, b shows the P-value distribution of values for the 
WL effect on respectively fasting metabolite levels and their 
postprandial response as expressed by iAUC. Comparing 
fasting and the challenge response between obese subjects 
that underwent WL or control interventions, we found that 
a range of metabolites are significantly different between 
two groups in either comparison. Figure 2a, b also show 
that there is a more pronounced effect at fasting as compared 
to the postprandial response. Metabolites that are signifi-
cantly different between groups at fasting (Supplementary 
Table S2A) are not changed upon a mixed meal challenge 
(Supplementary Table S2B). Branched chain amino acids 
(BCAA) and amino acid derived acylcarnitines (AAAC) 
were among the most significantly different metabolites 
between groups in the fasting state.
3.1.2  Polyphenol intervention study
The P-value distribution of the PP intervention effect on 
metabolite fasting state and response (iAUC) values are pre-
sented in Fig. 2c, d, respectively. The P-value distribution 
shows that only a small number of metabolites are different 
between two groups either at fasting or in their postprandial 
response. This also in line with the small number of metabo-
lites on which the PP intervention had a significant effect 
according to univariate testing (Supplementary Table S3A 
and B).
3.1.3  Correlation with phenotype parameters
For the WL study population a number of univariate correla-
tions between metabolite levels and HOMA can be estab-
lished (Fazelzadeh et al. 2018). The correlations between 
HOMA and branched chain amino acids, phenylalanine and 
tyrosine are in line with previous studies (Newgard 2012; 
Newgard et al. 2009). In addition, we could also find cor-
relations between HOMA and  C2/Cn acylcarnitine ratios, 
which were recently brought forward as putative read-outs 
for β-oxidation rate (Krug et al. 2012). In an earlier study, 
we also found correlation between HOMA and Δ nadir 
and nadir acylcarnitine levels, in particular for amino acid 
derived ones (Fazelzadeh et al. 2018). The Δ nadir and nadir 
acylcarnitine values can be considered as a single param-
eter summary of their postprandial response (Ramos-Roman 
et al. 2012) and the correlations with HOMA suggest they 
are related to fatty acid oxidation flux.
For the PP intervention study, we can observe a num-
ber of significant correlations between these phenotypi-
cal parameters with metabolites at fasting (Supplemen-
tary Table  S4). These correlations however provide a 
scattered view on involvement of metabolic pathways. 
 C2/2-methylbutyroylcanitine significantly correlated with 
HOMA (P = 0.02, ρ = − 0.31), but not with ΔRQ, or fat oxi-
dation. ∆nadir and nadir acylcarnitine levels with pheno-
typic parameters (HOMA, ΔRQ, fat oxidation) did not show 
any significant correlations.
3.2  Goeman’s global test for assessment 
of intervention effects on plasma metabolome
Metabolites from the TCA cycle and the lactate pathway 
were grouped according to the KEGG database. For amino 
acid and fatty acid derived acylcarnitines no pathway infor-
mation has been entered in KEGG. Hence we grouped 
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metabolites according to branched amino acid catabolism, 
comprising branched chain amino acids and derived acyl-
carnitines (AAACs, C3, C4, C4DC, C5). Fatty acid derived 
acylcarnitines (FAACs, C8–C18) were also grouped into 
one pathway. We also grouped phenylalanine and tyrosine, 
since both these amino acids have consistently been associ-
ated with insulin resistance (Newgard et al. 2009). Oxylipins 
derived from arachidonic acid were also grouped in a path-
way. An overview of metabolites collected in pathways is 
given in Table 1. The result of Goeman’s global testing 
for assessment of lean versus obese differences and effect 
of WL in obese is presented in Table 2. Three pathways, 
including the TCA cycle and BCAA catabolism are different 
between obese and lean subjects at fasting. The combination 
of phenylalanine and tyrosine was also significantly differ-
ent between lean and obese. The last two pathways were 
also different between obese subjects before and after a WL 
intervention. Regarding the postprandial metabolic response, 
the difference between obese and lean subjects was limited 
to lactate and the Arg–Pro pathway. We note that here we 
present effects for iAUC values, which account for positive 
and negative contributions. The effects are similar when 
piAUC values are considered (Supplementary Table S5). 
The Goeman’s global test did however not reveal significant 
(p > 0.05) WL induced differences in postprandial response 
in obese subjects. The effect of WL on the enzymatic oxida-
tion pathway of arachidonic acid did not reach statistical sig-
nificance (p < 0.09). The Goeman’s global testing approach 
was also deployed to reveal pathways that were affected by 
the PP intervention. No significant effect could however be 
observed for neither fasting metabolite levels nor the meta-
bolic postprandial responses, irrespective of whether iAUC 
or piAUC values were used.
3.3  Goeman’s global test for assessment 
of correlations of plasma metabolome 
with phenotypical variables
The populations of the WL and PP intervention studies 
were well characterized with respect to insulin sensitivity 
(HOMA), MF (RQ) and fasting state fat oxidation (Sup-
plementary Table S1a, b). HOMA was determined in both 
the WL and PP intervention studies, whereas RQ and fasting 
state fat oxidation were only determined in the PP study. 
We explored whether the Goeman’s global testing approach 
would provide a means to establish correlations between 
phenotype parameters and metabolic pathways. Goeman’s 
global test revealed that for the population of the WL inter-
vention study HOMA correlated with the fasting levels of 
metabolites from the TCA cycle, BCAA catabolism, lac-
tate–glucose, arginine–proline and phenylalanine–tyros-
ine pathways (Table 3). For this population the correlation 
between pathways and HOMA were more pronounced at 
fasting and less in the postprandial response as expressed 
by iAUC (Table 3) or piAUC (Supplementary Table S5).
For the PP study Goeman’s global test revealed that 
HOMA is correlated with TCA cycle (P = 0.02) and fatty 
acid oxidation pathways (P = 0.06) as observed in fasting 
levels (Table 3). For ΔRQ, fat oxidation, hepatic insulin 
resistance and peripheral insulin sensitivity no correlations 
could be established for any of the pathways when fasting 
levels were considered. Goeman’s test also found no correla-
tions between any of the phenotypical parameters (HOMA, 
ΔRQ, fat oxidation, hepatic insulin resistance, peripheral 
insulin sensitivity) and postprandial responses (iAUC and 
piAUC) when these were grouped in pathways.
Table 1  Collection of metabolites in pathways for Goeman’s global testing, for more detail on the metabolites see Supplementary Table S6
Pathway Number of metabolites in the 
group
Metabolites
TCA cycle 8 Citric acid, malic acid, 2-ketoglutaric acid, succinic acid, fumaric 
acid, pyroglutamic acid, cis-aconitic acid, pyruvate
BCAA catabolism 8 Val, lle, Leu, Amino acid acylcarinitnes (AAACs): C3, C4, C4DC, 
C5-Leu, C5-Ile
Fatty acid oxidation 16 Fatty acid acylcarnitines (FAACs): C6.0, C8.0, C8.1, C9.0, C10.0, 
C10.1, C12.0, C12.1, C14.0, C14.1, C14.2, C16.0, C16.1, C18.0, 
C18.1, C18.2
Lactate pathway 3 Lactate, pyruvate, glucose
Arg, Pro 6 Methionine, proline, ornithine, citrulline, 4-hydroxyproline, arginine
Phe, Tyr 2 Phenylalanine, tyrosine
Enzymatic oxidation of arachidonic 
acid
5 TXB2, PGE2, 12S.HHTrE, 5.HETE, 11.HETE
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4  Discussion
4.1  Global testing of intervention effects 
on metabolic pathways
We applied Goeman’s global test to determine whether sets 
of metabolites that are connected within a pathway collec-
tively respond to an intervention. Our aim was to examine 
whether a phenotypic flexibility can be defined as a shift 
in fasting metabolism or by the postprandial metabolic 
response. A study by Hendrickx et  al. (2012) revealed 
that Goeman’s global test can be used to determine if the 
behaviour of a group of metabolites within the same path-
way, is related to a specific outcome of interest. We applied 
the Goeman’s global test on two studies where volunteers 
respectively underwent a WL and PP intervention. The WL 
intervention caused a more pronounced shift in fasting lev-
els (T0) rather than in postprandial response as is shown 
in P distribution plot in Fig. 2. For the WL intervention 
Goeman’s global tests indeed showed significant effects at 
pathway level at fasting (Table 2). Metabolites involved in 
the TCA cycle have significantly different pattern between 
obese and lean subjects at fasting, which is in line with other 
studies (Newgard et al. 2009). Moreover, we observed an 
effect of WL on BCAA catabolism, and the combination 
of Phe–Tyr, which is in line with previous observations of 
changes in metabolic profiles accompanying an improvement 
in insulin resistance (Newgard 2012; Newgard et al. 2009). 
In previous work (Fazelzadeh et al. 2018), we observed that 
the main metabolites for which the postprandial response 
was different before/after WL were oxylipins derived from 
arachidonic acid by enzymatic oxidation. Although the indi-
vidual P values were significant for arachidonic acid derived 
oxylipins, when we test them collectively in Goeman’s test 
the effect of WL on the postprandial response of this path-
way was only P = 0.09.
In the dietary PP intervention study, the P distribution 
plot indicated that only a small number of metabolites were 
affected in the fasting state (T0) or in their postprandial 
response. This was also reflected in the small number of 
metabolites that showed a significant effect according to uni-
variate testing (Supplementary Table S3). Goeman’s global 
test indeed did not reveal any pathways that were signifi-
cantly different before and after the PP intervention. This 
is in line with the relative small effect of the PP interven-
tion on phenotypical parameters. Although the prolonged 
PP supplementation stimulated fat oxidation and increased 
mitochondrial capacity comparing to placebo, no significant 
Table 2  Goeman’s global 
testing of differences in 
metabolic pathways (Table 1) 
between lean and obese 
volunteers and the effect of a 
WL intervention [compared to a 
control (CRT) intervention]
Differences were tested for fasting state values (T0) and postprandial response (iAUC)
Pathways and number of 
metabolites
Fasting Response
T0 ∆T0 iAUC ∆iAUC 
Obese versus 
lean
WL versus 
CRTL
Obese versus lean WL versus CRTL
TCA cycle 8 0.01 0.2 0.4 0.3
BCAA catabolism 7 0.02 0.02 0.5 0.5
Fatty acid oxidation 16 0.07 0.4 0.7 0.5
Lactate pathway 3 0.06 0.5 0.03 0.3
Arg, Pro 6 0.5 0.1 0.02 0.6
Phe, Tyr 2 0.01 0.03 0.3 0.3
Enzymatic oxidation of 
arachidonic acid
5 0.6 0.5 0.3 0.09
Table 3  Goeman’s global test results for correlations between fasting 
state values, postprandial response (expressed as iAUC) and HOMA
The Goeman’s global tests were performed separately for volunteers 
from the WL and PP intervention studies. No significant effects were 
observed of effect of PP intervention on postprandial response. Note 
that no arachidonic acid (AA) metabolites (oxylipins) were measured 
for the PP intervention study. P-values ≤ 0.05 are indicated in bold
Pathways and number 
of metabolites
Fasting Post-
prandial 
response
Weight loss 
intervention 
group
Polyphenol 
intervention 
group
Weight 
loss 
inter-
vention 
group
TCA cycle 8 0.01 0.02 0.4
BCAA catabolism 7 0.04 0.4 0.6
Fatty acid oxida-
tion
16 0.7 0.06 0.4
Lactate pathway 3 0.05 0.9 0.02
Arg, Pro 6 0.04 0.6 0.7
Phe, Tyr 2 0.02 0.04 0.5
Enzymatic oxida-
tion of arachi-
donic acid
5 0.7 0.6 0.4
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effect on tissue-specific insulin sensitivity and MF in obese 
subjects was observed (Most et al. 2016).
4.2  Goeman’s global testing of correlations 
between pathways and phenotype parameters
The observed correlations of HOMA with metabolites 
involved in TCA cycle, BCAA catabolism and lactate path-
way can be explained by their positive correlation with 
insulin resistance (Newgard et al. 2009; Newgard 2012). 
However, Goeman’s global test showed that the changes in 
postprandial response are smaller than the change at fasting 
after the intervention (Table 3). In the population of the WL 
study, more pathways were significant than for the PP inter-
vention study, in particular at fasting. As the HOMA range 
of obese subjects for of two studies is comparable (Supple-
mentary Table S1a, b), the lack of pronounced effects in PP 
study might be due lack of power and/or confounding with 
other phenotype parameters.
5  Conclusion
The application of Goeman’s global test to two intervention 
studies indicates that it can provide a direct view on involve-
ment of a priori defined pathways in phenotype shifts. The 
effect of WL intervention on a priori defined metabolic 
pathways was consistent with previous studies, as well as 
correlation of pathways with insulin sensitivity as described 
by HOMA. Goeman’s global test, indicated that in the two 
intervention studies shifts in metabolic phenotype were more 
strongly reflected in pathways observed at baseline, than in 
their postprandial response. This confirms the biological 
interpretation of univariate tests performed in these studies.
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